Teo ZL, Tham Y-C, Yu MCY, Chee ML, Rim TH, Cheung N et al. Global prevalence of Diabetic Retinopathy and Projection of Burden through 2045: systematic review and Meta-analysis. Ophthalmology. 2021.

Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–64.

Article  PubMed  PubMed Central  Google Scholar 

Crawford TN, Alfaro DV III, Kerrison JB, Jablon EP. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev. 2009;5(1):8–13.

Article  CAS  PubMed  Google Scholar 

Nentwich MM, Ulbig MW. Diabetic retinopathy-ocular complications of diabetes mellitus. World J Diabetes. 2015;6(3):489.

Article  PubMed  PubMed Central  Google Scholar 

Capitão M, Soares R. Angiogenesis and inflammation crosstalk in diabetic retinopathy. J Cell Biochem. 2016;117(11):2443–53.

Article  PubMed  Google Scholar 

Gologorsky D, Thanos A, Vavvas D. Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy. Mediators Inflamm. 2012;2012.

Oh IK, Kim S-W, Oh J, Lee TS, Huh K. Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. Curr Eye Res. 2010;35(12):1116–27.

Article  CAS  PubMed  Google Scholar 

Leal MC, Casabona JC, Puntel M, Pitossi FJ. Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson’s disease? Front Cell Neurosci. 2013;7:53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shih R-H, Wang C-Y, Yang C-M. NF-kappaB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci. 2015;8:77.

Article  PubMed  PubMed Central  Google Scholar 

Park MH, Hong JT. Roles of NF-κB in cancer and inflammatory diseases and their therapeutic approaches. Cells. 2016;5(2):15.

Article  PubMed  PubMed Central  Google Scholar 

Li Q, Verma IM. NF-κB regulation in the immune system. Nat Rev Immunol. 2002;2(10):725–34.

Article  CAS  PubMed  Google Scholar 

Gasparini C, Feldmann M. NF-κB as a target for modulating inflammatory responses. Curr Pharm Des. 2012;18(35):5735–45.

Article  CAS  PubMed  Google Scholar 

Robinson R, Srinivasan M, Shanmugam A, Ward A, Ganapathy V, Bloom J, et al. Interleukin-6 trans-signaling inhibition prevents oxidative stress in a mouse model of early diabetic retinopathy. Redox Biol. 2020;34:101574.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J-X, Chen Y, DeBusk L, Lin W, Lin PC. Dual functional roles of Tie-2/angiopoietin in TNF-α-mediated angiogenesis. Am J Physiol Heart Circ Physiol. 2004;287(1):H187–H95.

Article  CAS  PubMed  Google Scholar 

Yoo S-A, Bae D-G, Ryoo J-W, Kim H-R, Park G-S, Cho C-S, et al. Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-α and IL-6 by human monocytes. J Immunol. 2005;174(9):5846–55.

Article  CAS  PubMed  Google Scholar 

Nagy JA, Dvorak AM, Dvorak HF. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol Mech Dis. 2007;2:251–75.

Article  CAS  Google Scholar 

Bonnin S, Dupas B, Lavia C, Erginay A, Dhundass M, Couturier A, et al. Anti–vascular endothelial growth factor therapy can improve diabetic retinopathy score without change in retinal perfusion. Retina (Philadelphia Pa). 2019;39(3):426.

Article  CAS  PubMed  Google Scholar 

Haddad JJ, Harb HL. Cytokines and the regulation of hypoxia-inducible factor (HIF)-1α. Int Immunopharmacol. 2005;5(3):461–83.

Article  CAS  PubMed  Google Scholar 

Robinson PJ, Hack C, Merrill EA, Mattie DR. Mathematical model of HIF-1 alpha pathway, oxygen transport and hypoxia. Henry M. Jackson Foundation For the Advancement of Military Medicine Wright…; 2017

Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003;9(6):677–84.

Article  CAS  PubMed  Google Scholar 

Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol. 2001;13(2):167–71.

Article  CAS  PubMed  Google Scholar 

Zhang D, Lv F, Wang G. Effects of HIF-1α on diabetic retinopathy angiogenesis and VEGF expression. Eur Rev Med Pharmacol Sci. 2018;22(16):5071–6.

CAS  PubMed  Google Scholar 

Wei J, Jiang H, Gao H, Wang G. Blocking mammalian target of rapamycin (mTOR) attenuates HIF-1α pathways engaged-vascular endothelial growth factor (VEGF) in diabetic retinopathy. Cell Physiol Biochem. 2016;40(6):1570–7.

Article  CAS  PubMed  Google Scholar 

Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M, et al. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest. 2003;111(12):1835–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruberte J, Ayuso E, Navarro M, Carretero A, Nacher V, Haurigot V, et al. Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease. J Clin Invest. 2004;113(8):1149–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong L, Nian H, Shao Y, Zhang Y, Li Q, Yi Y, et al. PTB-associated splicing factor inhibits IGF-1-induced VEGF upregulation in a mouse model of oxygen-induced retinopathy. Cell Tissue Res. 2015;360(2):233–43.

Article  CAS  PubMed  Google Scholar 

Sall JW, Klisovic DD, O’Dorisio MS, Katz SE. Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells. Exp Eye Res. 2004;79(4):465–76.

Article  CAS  PubMed  Google Scholar 

Nadjar A, Berton O, Guo S, Leneuve P, Dovero S, Diguet E, et al. IGF-1 signaling reduces neuro-inflammatory response and sensitivity of neurons to MPTP. Neurobiol Aging. 2009;30(12):2021–30.

Article  CAS  PubMed  Google Scholar 

Labandeira-Garcia JL, Costa-Besada MA, Labandeira CM, Villar-Cheda B, Rodríguez-Perez AI. Insulin-like growth factor-1 and neuroinflammation. Front Aging Neurosci. 2017;9:365.

Article  PubMed  PubMed Central  Google Scholar 

Nafeeza M, Norzana A, Jalaluddin H, Gapor M. The effects of a tocotrienol-rich fraction on experimentally induced atherosclerosis in the aorta of rabbits. Malays J Pathol. 2001;23(1):17–25.

CAS  PubMed  Google Scholar 

Kuhad A, Chopra K. Tocotrienol attenuates oxidative–nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy. Neuropharmacology. 2009;57(4):456–62.

Article  CAS  PubMed  Google Scholar 

Pervez MA, Khan DA, Ijaz A, Khan S. Effects of delta-tocotrienol supplementation on liver enzymes, inflammation, oxidative stress and hepatic steatosis in patients with nonalcoholic fatty liver disease. Turk J Gastroenterol. 2018;29(2):170.

Article  PubMed  PubMed Central  Google Scholar 

Nur Azlina MF, Kamisah Y, Chua KH, Ibrahim IAA, Qodriyah HMS. Preventive effects of tocotrienol on stress-induced gastric mucosal lesions and its relation to oxidative and inflammatory biomarkers. PLoS ONE. 2015;10(10):e0139348.

Article  PubMed  PubMed Central  Google Scholar 

Kuhad A, Chopra K. Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway. Life Sci. 2009;84(9–10):296–301.

Article  CAS  PubMed  Google Scholar 

Chin K-Y, Mo H, Soelaiman I-N. A review of the possible mechanisms of action of tocotrienol–a potential antiosteoporotic agent. Curr Drug Targets. 2013;14(13):1533–41.

Article  CAS  PubMed  Google Scholar 

Siveen KS, Ahn KS, Ong TH, Shanmugam MK, Li F, Yap WN, et al. γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model. Oncotarget. 2014;5(7):1897.

Article  PubMed  PubMed Central  Google Scholar 

Shibata A, Nakagawa K, Sookwong P, Tsuduki T, Tomita S, Shirakawa H, et al. Tocotrienol inhibits secretion of angiogenic factors from human colorectal adenocarcinoma cells by suppressing hypoxia-inducible Factor-1 α. J Nutr. 2008;138(11):2136–42.

Article  CAS  PubMed  Google Scholar 

Selvaduray KR, Radhakrishnan AK, Kutty MK, Nesaretnam K. Palm tocotrienols decrease levels of pro-angiogenic markers in human umbilical vein endothelial cells (HUVEC) and murine mammary cancer cells. Genes Nutr. 2012;7(1):53–61.

Article  CAS  PubMed  Google Scholar 

Manu KA, Shanmugam MK, Ramachandran L, Li F, Fong CW, Kumar AP, et al. First evidence that γ-Tocotrienol inhibits the growth of human gastric Cancer and chemosensitizes it to Capecitabine in a Xenograft Mouse Model through the modulatio